Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.-Reference-Cited by-同舟云学术

Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.

Published:1986-12-01 Issue:12 Volume:49 Page:1374-1377
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:Journal of Neurology, Neurosurgery & Psychiatry

Author:

Jolkkonen J,Soininen H,Halonen T,Ylinen A,Laulumaa V,Laakso M,Riekkinen P

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference27 articles.

1. How common is dementia in Parkinson's disease?;Brown, R.G.; Marsden, C.D.;Lancet,1984

2. The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem;Alvard, E.; Forna, L.S.; Kusse, J.A.; Kauffman, R.J.; Rhodes, J.S.; Goetowski, C.R.;Adv Neurol,1979

3. Dementia in Parkinson's disease: a neuropathological study;Hakim, A.M.; Mathieson, G.;Neurology,1979

4. Parkinson's disease: clinicopathological correlations;Boller, F.; Mizutani, T.; Roessmann, U.; Gambetti, P.;Ann Neurol,1980

5. Dementia associated with Parkinson's disease: a genetic study;Heston, L.L.;J Neurol Neurosurg Psychiatry,1980

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease;Frontiers in Cellular Neuroscience;2014-11-11

2. Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach;Neurobiology of Disease;2010-09

3. Neurochemical biomarkers in the differential diagnosis of movement disorders;Movement Disorders;2009-05-01

4. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease ? effect of L-Dopa;Journal of Neural Transmission;1996-05

5. Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: Altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin;Neuropeptides;1995-12